Compound information
- Natural Products
- ZC902694
- Molecular Formula
- C15H18N4O2S
- Molecular Weight
- 318.115046816 g/mol
- Structure
-
- IUPAC Name
- 4-(hydroxymethyl)-N-(3-phenyl-1,2,4-thiadiazol-5-yl)piperidine-1-carboxamide
- InChI
- InChI=1S/C15H18N4O2S/c20-10-11-6-8-19(9-7-11)15(21)17-14-16-13(18-22-14)12-4-2-1-3-5-12/h1-5,11,20H,6-10H2,(H,16,17,18,21)
- InChI Key
- NKWRLDBDLDLXEB-UHFFFAOYSA-N
- SMILES
- O=C(Nc1nc(-c2ccccc2)ns1)N1CCC(CO)CC1
- Source
- ZINC000065798464
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 78.35 Å2 | LogP | 2.52 |
LogS | -3.867 | LogD | 3.042 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.141 | Pgp substrate | 0.141 |
HIA | 0.952 | F20 % | 0.994 |
F30 % | 0.944 | Caco-2 | -4.574 |
MDCK | -5.168 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.335 | PPB | 89.652 |
VD | 0.865 | Fu | 1.15 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.857 | CYP1A2 substrate | 0.578 |
CYP2A6 substrate | 0.472 | CYP2B6 substrate | 0.709 |
CYP2C19 inhibitor | 0.625 | CYP2C19 substrate | 0.61 |
CYP2C8 substrate | 0.531 | CYP2C9 inhibitor | 0.762 |
CYP2C9 substrate | 0.066 | CYP2D6 inhibitor | 0.043 |
CYP2D6 substrate | 0.794 | CYP2E1 substrate | 0.156 |
CYP3A4 inhibitor | 0.014 | CYP3A4 substrate | 0.948 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.497 | CL | 7.67 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.439 |
Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.038 |
FDAMDD | 0.061 | Skin Sensitization | 0.834 |
Carcinogenicity | 0.171 | Eye Corrosion | 0.003 |
Eye Irritation | 0.012 | Respiratory Toxicity | 0.917 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.048 | IGC50 | 2.28 |
LC50FM | 3.646 | LC50DM | 2.126 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.672 | NR-AR-LBD | 0.228 |
NR-AhR | 0.952 | NR-Aromatase | 0.058 |
NR-ER | 0.661 | NR-ER-LBD | 0.336 |
NR-PPAR-gamma | 0.566 | SR-ARE | 0.715 |
SR-ATAD5 | 0.795 | SR-HSE | 0.154 |
SR-MMP | 0.716 | SR-p53 | 0.308 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.